EPL Ltd Q3 FY2024 Concall Summary

Key Takeaways

• Margin obsession delivering results: EBITDA margin hit 18.8%, up 224 bps YoY, driven by active price management and middle-of-P&L productivity disciplines forged in the commodity crisis.
• Revenue growth masked by negative pricing: Reported revenue grew just 3.2% as soft commodity costs flowed through to lower selling prices; underlying volume growth is stronger, and this pricing drag likely persists for two more quarters.
• Personal Care & Beyond is the growth engine: Now 48% of sales, this category is the path to double-digit growth, with smaller customers and pharma providing high-ASP, margin-accretive volume that oral care alone cannot deliver.
• Europe margin fix is in motion but not yet visible: Structural cost interventions have started; benefits are promised to begin flowing in Q4, making the next quarter the first real test of that commitment.
• What to watch next quarter: Whether Europe's cost actions actually lift margins, the pace of NEOSeam customer wins now that commercial supply has begun, and any sign that negative pricing is abating as flagged.

Margin: The Path to 20%

• The 20% obsession: Management is "obsessed with hitting two in front of our margin numbers," a target now within reach after a 224 bps YoY climb to 18.8%. The first goal is to breach 20%, after which management will apply judgment on the right growth-margin balance.
• Two durable muscles built: Active price management (monthly customer-level gross margin reviews) and middle-of-P&L productivity were learned during the commodity crisis and are "there to stay with us for a long time." Before the crisis, EPL had never taken more than 1-2% annual pricing in 40 years.
• Europe is the drag: Europe margins have declined sequentially; structural cost optimization has begun but benefits have not yet played through. Management says benefits will begin to flow in Q4 and beyond, making the next quarter a credibility checkpoint.
• Brazil turns accretive: The new greenfield plant has stabilized and is now included in consolidated results; margins are "very encouraging" and accretive to both Americas and global business.
• Ocean freight is a pass-through: Red Sea disruptions have increased lead times and forced higher safety stocks, but freight cost increases are passed through contractually; the margin impact is likely immaterial.

Kripalu: "I think you should absolutely count on the fact that management is, I would say, obsessed with hitting two in front of our margin numbers and we are going to leave no stone unturned to get there."

Revenue Growth: The Pricing Overhang

• Negative pricing masks real demand: Revenue grew 3.2% but soft commodity prices flowed through to lower selling prices roughly a quarter later, compressing the reported number. Volume growth is stronger by deduction, though management declines to disclose it, citing 20-25x ASP differences across geographies and categories that make unit comparisons misleading.
• Two more quarters of drag: Assuming commodities stay where they are, management expects "a couple more quarters of some level of negative pricing." No fresh negative pricing is being given; some customers are being negotiated with and pricing is being held out as long as possible.
• AMESA weighed down by Egypt: India standalone grew 4.2%, but Egypt's significant economic challenges, currency issues and devaluation dragged AMESA to negative 0.6%.
• Seasonality matters: Q3 (Oct-Dec) is softer in Western geographies due to Christmas shutdowns; Q4 (Jan-Mar) is softer in EAP because of Chinese New Year. Management urges year-on-year comparisons, not sequential.[15-16]

Personal Care & Beyond: The Growth Engine

• 48% of sales and climbing: Personal Care & Beyond now contributes nearly half of YTD revenue, with significant gains in pharma where India hit its highest-ever revenue in December 2023. Oral care alone will never deliver double-digit growth; beauty, cosmetics and pharma are the high-headroom categories.
• Smaller customers, higher margins: Global wallet share in Personal Care & Beyond is sub-10%, so the strategy targets smaller customers. While manufacturing smaller lot sizes costs more, ASPs are typically higher, and the intent is for this category to be margin accretive. China has had significant success with "local king" skin care brands at very high pricing per tube and shorter lead times.
• Management declines to quantify the premium: Asked how much incremental profit smaller quantities deliver versus bulk, management called it "very hard for me to give you a number because it is a strategic priority."

Sustainability & NEOSeam: The Competitive Moat

• 90% of capacity is recyclable-ready: EPL believes it is significantly ahead of competition, positioning to capture disproportionate share as customer conversion commitments draw closer. The company is on track to double recyclable tube sales versus the prior year, reaching 20% of total volume.
• NEOSeam goes commercial: The near-seamless lamitube technology has begun commercial supply across India, Europe and the US; it is no longer just an idea. The attempt now is to win more customers and more business for the technology.
• Conversion risk runs the other way: Management's stated concern is not that conversion will be too slow, but that it "may happen faster than we are ready for." The company is targeting 60% recyclable volume perhaps two years out.

Kripalu: "I don't think that the risk is only, when I've seen, when conversions like this happen, I think the only risk is that the conversion may happen faster than we are ready for."

Brazil & Capacity Expansion

• Brazil greenfield stabilized: The plant became operational last quarter and has now stabilized; from this quarter, EPL presents a consolidated view including Brazil. Civil site and utilities have space for further lines to be added at shorter notice as demand builds.[14-15]
• Customer interest broadening: Beyond anchor customers, conversations have started with many other customers. Further fill-up of the site will be managed as new demand and orders come in.

Capital Allocation & M&A

• Hungry but disciplined: Management is "absolutely hungry for M&A" but insists on growth-accretive, margin-accretive targets with strategic synergies at the right price. The Europe environment is not right for a major investment at this point. Some targets were looked at very closely and would have been considered at a "throwaway price." [14-15]
• Export incentives: Other income includes export incentives against equipment imports and other subsidies. An accounting change from Q4 last year moved export liabilities from contingent liabilities below P&L into other income and amortizations, with no net profit impact.

Goyal: "So, see, there is a saying called never waste a good crisis. I think what we have used this crisis is to learn and develop a few very important muscles. One of them is active price management and second is the middle of the P&L productivity."

Guidance & Commitments

Key Metrics